National Comprehensive Cancer Network
Policy Summit: Developments in Biosimiliars and Molecular Testing - Article Coming Soon!
Patient Advocacy Summit: Value Tools for Patients in Cancer Care – Article Coming Soon!
Educational Events & Programs
NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business
The Organization and Structure of Cancer Policy in the United States: Roles, Programs, Influence, and Impact
This module addresses programs and information products and their influence on decisions that impact access to and availability of drugs, devices, and procedures to patients. Programs and products from patient (patient advocacy), provider (such as ASCO and NCCN), and other groups may be incorporated into the discussion and may include the following topics:
- The influence of the above groups in the legislative, regulatory, informational, and educational arenas
- The interaction or lack thereof, among governmental agencies such as the FDA, CMS, NCI, AHRQ, NIHCR, and others
- The decision-making processes for oncology policy in the United States as briefly contrasted with European Union countries, Canada, Australia, and large emerging markets